Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1295-1297
Published online before print May 5, 2005, doi: 10.1161/01.STR.0000166344.75440.b9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/1295    most recent
01.STR.0000166344.75440.b9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petzold, A.
Right arrow Articles by Sharpe, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petzold, A.
Right arrow Articles by Sharpe, T. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Laboratory Tests
Related Collections
Right arrow Other diagnostic testing
Right arrow Other Research

(Stroke. 2005;36:1295.)
© 2005 American Heart Association, Inc.


Research Reports

Why Human Color Vision Cannot Reliably Detect Cerebrospinal Fluid Xanthochromia

Axel Petzold, MD, PhD; Geoffrey Keir, PhD, MSc FRCPath FIBMS Ted L. Sharpe, PhD, MA

From the Tavistock Intensive Care Unit (A.P.), The National Hospital for Neurology and Neurosurgery, and Department of Neuroimmunology, Institute of Neurology, Queen Square, London, UK; the Department of Neuroimmunology (G.K.), Institute of Neurology, Queen Square, London, UK; and the Colour and Vision Research Laboratories (T.L.S.; http://cvrl.ioo.ucl.ac.uk/index.htm), Institute of Ophthalmology, London, UK.

Correspondence to Dr Axel Petzold, the Department of Neuroimmunology, Institute of Neurology, Queen Square, London WC1N 3BG, UK. E-mail a.petzold{at}ion.ucl.ac.uk

Background— Visual assessment of cerebrospinal fluid (CSF) for xanthochromia (yellow color) is practiced by the majority of laboratories worldwide as a means of diagnosing intracranical bleeds.

Methods— Colorimetric and spectrophotometric analysis of CSF samples for recognizing the presence of bilirubin either in low concentrations or in the presence of hemolysed blood.

Results— The experiments provide the physiological and colorimetric basis for abandoning visual assessment of CSF for xanthochromia.

Conclusion— We strongly recommend relying on spectrophotometry as the analytical method of choice.


Key Words: cerebrospinal fluid • intracerebral hemorrhage • subarachnoid hemorrhage




This article has been cited by other articles:


Home page
PediatricsHome page
L. E. Nigrovic, M. Trivedi, J. A. Edlow, and M. I. Neuman
Cerebrospinal Fluid Xanthochromia in Newborns Is Related to Maternal Labor Before Delivery
Pediatrics, November 1, 2007; 120(5): e1212 - e1216.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. J. Perry, M. L.A. Sivilotti, I. G. Stiell, G. A. Wells, J. Raymond, M. Mortensen, and C. Symington
Should Spectrophotometry Be Used to Identify Xanthochromia in the Cerebrospinal Fluid of Alert Patients Suspected of Having Subarachnoid Hemorrhage?
Stroke, October 1, 2006; 37(10): 2467 - 2472.
[Abstract] [Full Text] [PDF]